title: [Drug-related psoriasis].
abstract: Psoriasis is a common genetic disorder that may be initiated (drug-induced psoriasis) or exacerbated (drug-triggered psoriasis) by some drug intakes. Beta-blockers, lithium, some antimelarial drugs, non steroidal anti-inflammatory agents and tetracyclines are recognized to influence the clinical course of psoriasis. Other drugs are likely or possibly involved in this process.
authors.affiliation: Service de Dermatopathologie,CHU de Liège. claudine.franchimont@ulg.ac.be
authors.forename: C
authors.initials: C
authors.lastname: Piérard-Franchimont
authors.forename: G E
authors.initials: GE
authors.lastname: Piérard
mesh_terms: D058671:Adrenergic beta-1 Receptor Antagonists / Q000009:adverse effects; D000962:Antimalarials / Q000009:adverse effects / Q000138:chemical synthesis; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007049:Iatrogenic Disease; D008094:Lithium / Q000009:adverse effects; D011565:Psoriasis / Q000139:chemically induced*
chemical_list: D058671:Adrenergic beta-1 Receptor Antagonists; D000962:Antimalarials; D008094:Lithium